(lp0
S"Podcast: Supreme Pharmaceuticals CEO John Fowler on becoming Canada's next ... Financial Post - Apr 14, 2016 Supreme Pharmaceuticals Inc.   received its MMPR license from Health Canada, and has already started growing its first crop of cannabis."
p1
aS'Supreme Pharmaceuticals Announces Upsize of Previously Announced Bought Deal ... Canada NewsWire  - Nov 15, 2016 TORONTO, Nov. 15, 2016 /CNW/ - Supreme Pharmaceuticals Inc.   announced today that it has entered into a revised agreement with Canaccord Genuity Corp.'
p2
aS"Massive license puts Supreme Pharmaceuticals in medical marijuana driver's seat Proactive Investors USA & Canada - Jun 9, 2014 The big competitive advantage we have is that we have been approved for our proposed MMPR license for 24,000 kg per year, and I know of no bigger license than that, explains Supreme's president and CEO David Stadnyk, referring to the company's&nbsp;..."
p3
aS'Supreme Pharmaceuticals Inc. Announces Brayden R. Sutton as Executive Vice ... Marketwired  - Aug 28, 2014 VANCOUVER, BRITISH COLUMBIA-- - Supreme Pharmaceuticals Inc.   is pleased to announce Brayden R. Sutton as Executive Vice President.'
p4
aS'Supreme Pharmaceuticals Inc. Announces Second Acquisition Target Marketwired  - May 13, 2014 VANCOUVER, BRITISH COLUMBIA-- - Supreme Pharmaceuticals Inc.   is pleased to report that the Company has signed a letter of intent  to acquire a green house&nbsp;...'
p5
aS'Supreme Pharmaceuticals Inc. Announces Share Consolidation Marketwired  - Jul 18, 2014 VANCOUVER, BRITISH COLUMBIA-- - Supreme Pharmaceuticals Inc.   announces that it will be proceeding with a 5 to 1 share consolidation such that a holder of 5&nbsp;...'
p6
aS'Stock Watch: Focusing in on Supreme Pharmaceuticals Inc.  SKV News - 11 hours ago Supreme Pharmaceuticals Inc.  currently has a 6 month price index of 1.41121. The six month price index is simply measured by dividing the current share price by the share price six months ago.'
p7
aS'Is Supreme Pharmaceuticals Inc.  Undervalued? Business Review - Mar 17, 2017 Supreme Pharmaceuticals Inc.  has an ERP5 rank of 13978. The ERP5 Rank is an investment tool that analysts use to discover undervalued companies.'
p8
aS'Health Canada Provides Cannabis Cultivation License to Supreme Pharmaceuticals New Cannabis Ventures  - Mar 11, 2016 TORONTO, ONTARIO - Supreme Pharmaceuticals Inc.   is pleased to announce its wholly-owned subsidiary, Advanced Medical Marihuana Canada &nbsp;...'
p9
aS'Supreme Pharmaceuticals Announces Additional, $5 Million Non-Brokered Private ... Marketwired  - Nov 17, 2016 Supreme Pharmaceuticals Inc.   is pleased to announce its intention to complete a non-brokered private placement  of up to $5 million of convertible debenture units on the same terms as the&nbsp;...'
p10
a.